About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
ESGO 2024 Insights: "The Movie Trial - Safety & Efficacy of Durvalumab + Tremelimumab + Metronomic Oral Vinorelbine in Pts With Recurrent/Metastatic Cervical Cancer"
By
Insights from 2024 ESGO Annual Meeting
FEATURING
Jean-Sebastien Frenel
By
Insights from 2024 ESGO Annual Meeting
FEATURING
Jean-Sebastien Frenel
49 views
March 19, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
23:46
AstraZeneca Oncology
First-line Maintenance Treatment Option in Patients With HRD-Positiv…
Feat.
S. Lewin
Featured Video
19:51
AstraZeneca Oncology
Management Strategies for Fatigue and Asthenia in First-line Mainten…
Feat.
D. Czel,
C. Arn
Related Content
AUTOPLAY
ON
27:04
Fengting Yan
Cancer Screening Molecular Tools
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
06:07
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "Key Updates in Gynecological Cancers"
Feat.
M. Raza Mirza
04:02
Total Health
2024 Updates in Cervical Cancer
Feat.
T. Tillmanns
15:14
Brian Slomovitz
Update in Vulvar and Vaginal Cancer
07:56
Fengting Yan
Year in Review: Cervical Cancer
13:41
UCLA Health
2024 Updates in Locally Advanced Cervical Cancer
Feat.
D. Chase
06:46
Total Health
Recent Highlights in Cervical Cancer
Feat.
B. Slomovitz
12:45
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "The GCIG INTERLACE Randomised Phase 3 Tria…
Feat.
M. McCormack
44:59
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Updates on Cervical and Endometrial Cancers
Feat.
K. Pennington
05:31
Insights from 2024 SGO Annual Meeting
SGO 2024 Insights: "Impact of Maintenance Bevacizumab Following…
Feat.
M. Kuznicki
04:58
Oncology Data Advisor
Tisotumab Vedotin for Metastatic Cervical Cancer: Updates From ESMO …
Feat.
B. Slomovitz
10:27
Robert McBane
2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…
11:37
UCLA Health
Recurrent Cervical Cancer Updates
Feat.
R. Salani
12:21
Insights from 2024 ESGO Annual Meeting
ESGO 2024 Insights: "PARP Inhibitor Resistance Mechanisms in Gy…
Feat.
V. Heinzelmann-Schwarz
07:03
Insights from 2024 SGO Annual Meeting
SGO 2024 Insights: "innovaTV 301/ENGOT-cx12/GOG-3057 Study - Ef…
Feat.
B. Slomovitz
11:02
SGO 2023 Conference Coverage on VuMedi
Chemoradiation for Stage IB3 Cervical Cancer
Feat.
J. Mayadev
07:05
Insights from 2024 ESGO Annual Meeting
ESGO 2024 Insights: "Understanding and Targeting BRCA & HRD…
Feat.
V. Heinzelmann-Schwarz
11:10
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "KEYNOTE-A18 Study - Pembro + CRT for High-…
Feat.
D. Lorusso
08:24
Hope Cottrill
Tisotumab Vedotin in Advanced or Recurrent Cervical Cancer
